MERS-CoV spike protein: Targets for vaccines and therapeutics
- 26 July 2016
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 133, 165-177
- https://doi.org/10.1016/j.antiviral.2016.07.015
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (C180501, 81461168030)
- China Ministry of Science and Technology National 973 Project (2015CB910500)
This publication has 148 references indexed in Scilit:
- Conditionals by inversion provide a universal method for the generation of conditional allelesProceedings of the National Academy of Sciences of the United States of America, 2013
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4Cell Research, 2013
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinScientific Reports, 2013
- A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus ChallengeScience Translational Medicine, 2011
- Clinical Applications of DNA Vaccines: Current ProgressClinical Infectious Diseases, 2011
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- SARS coronavirus accessory proteinsVirus Research, 2008
- Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common ThemeCritical Reviews in Biochemistry and Molecular Biology, 2008
- Virus membrane-fusion proteins: more than one way to make a hairpinNature Reviews Microbiology, 2006
- Identification of a new human coronavirusNature Medicine, 2004